McGarity Jon 4

What Happened Jon McGarity, a director of Klotho Neurosciences, received a grant of 350,000 common shares (transaction code A) on March 4, 2026. The filing lists price and aggregate value as N/A; the grant was made under the company’s Equity Incentive Plan (see footnote F1). This is an award/compensation issuance rather than a market purchase or sale.

Key Details

• Transaction date: 2026-03-04 (reported on Form 4 filed 2026-03-06)
• Transaction type: Award/Grant under Equity Incentive Plan (code A)
• Shares acquired: 350,000; price/aggregate value: N/A (reported as grant)
• Shares owned after transaction: Not disclosed in this filing
• Footnote: F1 — shares were issued as a grant under the company’s Equity Incentive Plan
• Filing timeliness: Reported two days after the transaction; appears timely under the 2-business-day Form 4 requirement

Context Grants under an equity incentive plan are typically part of compensation and may vest over time or be subject to restrictions; they do not by themselves indicate the insider’s intention to buy or sell additional shares. No exercise, sale, or tax-withholding details were reported in this Form 4.